Research – A world to explore

Like you, Roche is passionate about the research and scientific excellence that will lead to the healthcare breakthroughs of tomorrow. We’re tireless in the research and development of clinically differentiated pharmaceuticals and their application in key therapeutic areas such as oncology, inflammation, metabolism, virology and the central nervous system – as well as developing adequate diagnostic instruments to optimise healthcare. Thanks to our sustained efforts in the field of R&D, Roche is able to provide new medicines and methods of diagnosis to treat a variety of diseases.


As both a diagnostics and a pharmaceuticals company, we’re pioneering the area of “personalized healthcare” through the interface of diagnosis and treatment. We’re already marketing the first personalised medicinal products tailored to the needs of specific patient groups. As an example, the AmpliChip Test, which allows individualized dosing based on metabolic profiling, was the first pharmacogenetic test to be officially recognized by the FDA.


We offer you the opportunity to apply your experience, to assume responsibility and to join us in shaping the future – regardless of whether you’re at home in the field of biology, biochemistry, biotechnology, chemistry, pharmacy or engineering.

Roche has research sites around the world, including Switzerland, the United States, Germany, and Shanghai, China. Furthermore, Roche also has co-development partnerships with Genentech (USA) and Chugai (Japan).


Roche’s Pharma Research is focused on five disease biology areas 

• Oncology
• Metabolism
• Virology
• Inflammation
• Central Nervous System

Roche’s Research focuses on the following technological platforms: 

• Synthesis and Screening (“Ultra-High Throughput Screening“)
• Combinatorial Chemistry
• 3D Modelling
• Genetics, Genomics
• Pharmacogenetics
• Proteomics
• Bioinformatics

Biotechnology and other important research activities:
 
Thanks to a variety of new developments in the field of biotechnology, Roche has taken advantage of numerous new therapeutic approaches, particularly in oncology. We believe that the future of innovation will depend greatly on and be accelerated by advances in biotechnology – from therapeutic proteins to new developments in siRNA technologies as well as advances in biomarkers, translational medicine and bioinformatics.


If Roche Research sounds like the type of challenge you are looking for, then take a look at our exciting range of internships currently on offer. 

Our research teams have won a number of awards, including;

Nobel Prize in Physiology or Medicine

1987 Awarded to Susumu Tonegawa, Basel Institute for Immunology (BII), for his work on the genetic origins of antibody diversity

1984 Awarded to Niels Kaj Jerne, together with Georges Köhler, Basel Institute for Immunology (BII), and César Milstein, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom for the discovery of monoclonal antibodies


Prix Galien prizes

2004 International Prix Galien for Fuzeon

1998 European Prix Galien for Invirase

1998 Prix Galien for Anexate

1992 International Prix Galien for Neupogen


You could help us win the next one!